Chulabhorn Royal College prepares to import monoclonal antibody drug
On September 21, 2021 at 2:28 p.m.
The Royal College of Chulabhorn prepares to import “monoclonal antibody” drug to distribute to various hospitals to increase treatment options for covids.
Dr. Nithi Mahanon, secretary-general of the Chulabhorn Royal College Addressing the situation of the coronavirus disease 2019 (Covid-19) epidemic and plans to manage the increase in infection in the future that Care for COVID patients has increased dramatically since April. 64 In the past, until the infection in countries where the number of patients increased more than 20,000 per day, It is a very heavy burden on the country’s public health system. Including a huge social impact as well. Therefore, vaccination or antiviral drugs that are faster and more extensive will allow people to return to normal life faster
However, it is believed that this coronavirus will be with the world for a while. Until there is a vaccine that is effective enough. adequate medicine including logging in for quick treatments But in the meantime, the right care system is needed. From the self-protection process to learn and understand more about the disease including reducing the channels that lead to the point of having to be hospitalized to help alleviate the burden of the country’s public health
Dr. Nithi said that the Chulabhorn Royal College It will be part of the supply and distribution of “monoclonal antibodies”, which are antibody cocktails. The first to be designed to directly treat COVID-19 was created and developed to enable the infected body to effectively fight the virus and stop infection.
“The important point that the Royal College is doing is importing and distributing monoclonal drugs. Antibodies to various hospitals and together with hospitals in dispensing this drug. This is expected to happen soon in our country to test this drug. I don’t want the treatment of COVID to be limited to vaccinations,” said Dr. Nithi.
for the functioning of this antibody cocktail can weaken the virus directly binding to the protein barbs which is on the surface of the virus Therefore, it can stop infection within the body immediately. In addition, the drug can also inhibit the Covid-19 virus. Different breeds can help reduce the rate of hospital admissions. and reduce the mortality rate of patients
For the antibody cocktail regimen to treat patients in Thailand The “monoclonal antibody” drug will be used for patients diagnosed by a doctor as infected with COVID-19. Less than 10 days ago, mild to moderate symptoms and people with risk factors that will exacerbate their symptoms, such as the elderly, obesity, coronary heart disease, high blood pressure, chronic lung disease, asthma, diabetes, kidney disease, liver disease, and Immunodeficiency. However, there are currently limited data on the use of the drug in pregnant women. or during breastfeeding including children under 12 years old
Monoclonal antibodies stop the coronavirus from entering cells in the body. If starting to use from the first symptoms will heal faster mild symptoms reduce the mortality rate Help make caring for patients with this disease easier. It’s not a big burden on the public health system,” said Dr. Nithi.
Dr. Kamthorn Malatham, president of the Infectious Diseases Association of Thailand, said that the current situation in the treatment of coronavirus patients in the country has started to deteriorate somewhat from the previous number of infected people increasing more than 20,000 per day. At that time, there were 5% of patients with severe symptoms, but now the situation is getting better.
However, after starting to relax measures and start to open more activities, it may see more outbreaks again since mid-October. onwards, which can only hope that the number of outbreaks in this round will not be as steep as the previous outbreaks
At the same time, people may still need to ask for cooperation in reducing economic activities. There is still a need to work from home, as well as to comply with strict public health measures. because if everyone doesn’t cooperate It’s hard to stop the epidemic. including increasing the amount of vaccination to cover as much as possible Because although no vaccine is 100% effective against infection, vaccines can reduce serious illness. and reduce the mortality rate
Dr. Kamthorn said that fighting the ever-evolving virus A variety of treatment methods are needed. whether the vaccine or various drugs That has been invented and developed to keep up with the development of the virus. Monoclonal antibodies are another option to add more variety to the weapon in the fight against the coronavirus. It is expected that it will take at least half a year before the drug can be started in coronavirus patients.